Altamira Therapeutics Re-launches Bentrio in Europe for Allergic Rhinitis
Bentrio USA Altamira Therapeutics Re-launches Bentrio in Europe for Allergic Rhinitis HAMILTON, BERMUDA , Sept….
Bentrio USA Altamira Therapeutics Re-launches Bentrio in Europe for Allergic Rhinitis HAMILTON, BERMUDA , Sept….
Bentrio USA Altamira Therapeutics Re-launches Bentrio in Europe for Allergic Rhinitis HAMILTON, BERMUDA , Sept….
LAWRENCEVILLE, N.J., Sept. 27, 2022 (GLOBE NEWSWIRE) — Imunon, Inc. (NASDAQ: IMNN), a clinical-stage drug development…
LAWRENCEVILLE, N.J., Sept. 27, 2022 (GLOBE NEWSWIRE) — Imunon, Inc. (NASDAQ: IMNN), a clinical-stage drug development…
LAWRENCEVILLE, N.J., Sept. 27, 2022 (GLOBE NEWSWIRE) — Imunon, Inc. (NASDAQ: IMNN), a clinical-stage drug development…
CAMBRIDGE, Mass., Sept. 27, 2022 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
CAMBRIDGE, Mass., Sept. 27, 2022 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
CAMBRIDGE, Mass., Sept. 27, 2022 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
New study size of 140 patients for the REBUILD Study, without modifying trial objective or…
New study size of 140 patients for the REBUILD Study, without modifying trial objective or…
New study size of 140 patients for the REBUILD Study, without modifying trial objective or…
Companies Will Collaborate to Drive Digital Innovation, Adoption and Engagement SAN JOSE, Calif., Sept. 27,…
Companies Will Collaborate to Drive Digital Innovation, Adoption and Engagement SAN JOSE, Calif., Sept. 27,…
Companies Will Collaborate to Drive Digital Innovation, Adoption and Engagement SAN JOSE, Calif., Sept. 27,…
ISELIN, N.J. and CONSHOHOCKEN, Pa., Sept. 27, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq:…
ISELIN, N.J. and CONSHOHOCKEN, Pa., Sept. 27, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq:…
ISELIN, N.J. and CONSHOHOCKEN, Pa., Sept. 27, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq:…
Akari successfully closed a registered direct offering and concurrent private placement raising aggregate gross proceeds…
Akari successfully closed a registered direct offering and concurrent private placement raising aggregate gross proceeds…
Akari successfully closed a registered direct offering and concurrent private placement raising aggregate gross proceeds…